The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline polymorphisms in genes maintaining replication fork to predict the efficacy of oxaliplatin and irinotecan in metastatic colorectal cancer (mCRC) patients enrolled in MAVERICC trial.
 
Hiroyuki Arai
No Relationships to Disclose
 
Yi Xiao
No Relationships to Disclose
 
Jingyuan Wang
No Relationships to Disclose
 
Francesca Battaglin
Travel, Accommodations, Expenses - Caris Life Sciences
 
Natsuko Kawanishi
No Relationships to Disclose
 
Priya Jayachandran
No Relationships to Disclose
 
Shivani Soni
No Relationships to Disclose
 
Zhang Wu
No Relationships to Disclose
 
Christoph Mancao
Employment - Innovent Biologics; Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent
 
Bodour Salhia
(OPTIONAL) Uncompensated Relationships - CpG Diagnostics
 
Shannon M. Mumenthaler
No Relationships to Disclose
 
Joshua Millstein
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Isofol Medical; Merck Serono; Roche
Consulting or Advisory Role - Bayer; BMS; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono